1. Home
  2. ADVM vs ZEO Comparison

ADVM vs ZEO Comparison

Compare ADVM & ZEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • ZEO
  • Stock Information
  • Founded
  • ADVM 2006
  • ZEO 2005
  • Country
  • ADVM United States
  • ZEO United States
  • Employees
  • ADVM N/A
  • ZEO N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • ZEO
  • Sector
  • ADVM Health Care
  • ZEO
  • Exchange
  • ADVM Nasdaq
  • ZEO NYSE
  • Market Cap
  • ADVM 47.4M
  • ZEO 55.5M
  • IPO Year
  • ADVM 2014
  • ZEO N/A
  • Fundamental
  • Price
  • ADVM $2.39
  • ZEO $2.47
  • Analyst Decision
  • ADVM Strong Buy
  • ZEO
  • Analyst Count
  • ADVM 5
  • ZEO 0
  • Target Price
  • ADVM $23.80
  • ZEO N/A
  • AVG Volume (30 Days)
  • ADVM 122.9K
  • ZEO 54.2K
  • Earning Date
  • ADVM 08-11-2025
  • ZEO 08-18-2025
  • Dividend Yield
  • ADVM N/A
  • ZEO N/A
  • EPS Growth
  • ADVM N/A
  • ZEO N/A
  • EPS
  • ADVM N/A
  • ZEO N/A
  • Revenue
  • ADVM $1,000,000.00
  • ZEO $61,885,622.00
  • Revenue This Year
  • ADVM N/A
  • ZEO N/A
  • Revenue Next Year
  • ADVM $18.82
  • ZEO N/A
  • P/E Ratio
  • ADVM N/A
  • ZEO N/A
  • Revenue Growth
  • ADVM N/A
  • ZEO N/A
  • 52 Week Low
  • ADVM $1.78
  • ZEO $1.05
  • 52 Week High
  • ADVM $8.56
  • ZEO $4.00
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 42.53
  • ZEO 45.89
  • Support Level
  • ADVM $2.61
  • ZEO $2.41
  • Resistance Level
  • ADVM $2.82
  • ZEO $2.62
  • Average True Range (ATR)
  • ADVM 0.21
  • ZEO 0.18
  • MACD
  • ADVM -0.03
  • ZEO -0.01
  • Stochastic Oscillator
  • ADVM 8.57
  • ZEO 52.54

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About ZEO ZEO ENERGY CORP

Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy-efficient equipment, and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.

Share on Social Networks: